About Smilow Cancer Hospital Care Center - Westerly
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
7
ECOG-ACRIN Cancer Research Group
5
Alliance for Clinical Trials in Oncology
2
SWOG Cancer Research Network
1
Clinical Trials at Smilow Cancer Hospital Care Center - Westerly
During the past decade, Smilow Cancer Hospital Care Center - Westerly conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
2019-01-04
2027-06-01
Active, not recruiting
454
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital Care Center - Westerly"
#1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Smilow Cancer Hospital Care Center - Westerly
According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital Care Center - Westerly" are
"Breast Carcinoma" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Pancreatic Carcinoma" (2 trials), "Plasma Cell Myeloma" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Smilow Cancer Hospital Care Center - Westerly" in a lesser frequency.
Clinical Trials Intervention Types at Smilow Cancer Hospital Care Center - Westerly
Most popular intervention types in "Smilow Cancer Hospital Care Center - Westerly" are "Other" (13 trials), "Biological" (10 trials), "Drug" (10 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Computed Tomography" (6 trials), "Magnetic Resonance Imaging" (5 trials), "Questionnaire Administration" (5 trials) and "Biospecimen Collection" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Smilow Cancer Hospital Care Center - Westerly
The vast majority of trials in "Smilow Cancer Hospital Care Center - Westerly" are
13 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Smilow Cancer Hospital Care Center - Westerly
Currently, there are NaN active trials in "Smilow Cancer Hospital Care Center - Westerly".
undefined are not yet recruiting,
7 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Smilow Cancer Hospital Care Center - Westerly,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Smilow Cancer Hospital Care Center - Westerly, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".